Achilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022
– Early proof-of-concept data support durable clinical benefit including confirmed partial response and stable disease…
Lithosphere Deploys MultX to Enable Atomic Cross-Chain Execution on Makalu
American Aires Inc. Announces Change of Auditor
Zhibao Technology Announces 1H2026 Earnings Conference Call and Investor Webinar Participation
Integrated Quantum Technologies Announces Non-Brokered Private Placement of Units
TechCon Global Announces Dr. Irwin Jacobs as Recipient of the TechCon Fellows Lifetime Achievement Award